Hyperfine Inc HYPR

$0.52 -0.02 (-3.82%)

Valuation

Market cap
57,868,000
Revenue TTM
$13,560,000
Net income TTM
$-35,570,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-262.32%
Debt to equity
0.42

Trading

Volume
696,200
Avg volume
834,758
Day's range
$0.50 – $0.56
Shares out
106,199,000
Stochastic %K
10%
Beta
1.49
Analysts
Strong Buy
Price target
$2.02

Price

Company profile

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communicat...

Show more

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Industry
Medical Devices
Sector
Healthcare
Phone
866 796 6767
Website
https://www.hyperfinemri.com
Address
351 New Whitfield Street, Guilford, United States

Latest news

Stocktwits

Denzerini Nov 17, 9:23 PM
$HYPR The patient, and opportunistic, will be rewarded. The company continues to execute well with the proof being their continued sales growth, and consistent meeting and beating quarterly estimates. The margins will be expanding also once they receive FDA approval for contrast. The TAM is quite large — especially when including international. Then there are the 197 issued patents plus 160 pending. I understand that it is a major bummer to watch the stock sink every day, but this has been happening with most MedTech micro cap companies lately. Then there are the Russell 3000 funds that have to sell HYPR in the short term. As it always has done historically, the stock of a business that continues to beat/exceed its estimated sales growth, and at least maintains its margins, will eventually experience a sustainable long-term rise. This painful period should be viewed as a special opportunity to purchase stock at a discount while it’s floating under the radar.
1 replies
Number_4 Nov 17, 6:42 PM
$HYPR Should see 48-50 cents very soon snd I will cover. At 25 cents might go long a few waiting for Rothberg to pump it.
0 replies
WhitespringMcGee Nov 17, 3:30 PM
$HYPR I grabbed some down here
1 replies
alchemy2442 Nov 17, 3:14 PM
$HYPR What a FAHKING JOKE!
0 replies
RJcc Nov 15, 9:33 PM
$HYPR how has this gone this low
1 replies
Number_4 Nov 13, 8:51 PM
$HYPR $.50 handle next week, Maria and Brett are so awesome!
1 replies
Number_4 Nov 13, 5:48 PM
$HYPR Where is the insider buying at this price? Oh wait, the Chief Marketing Office Tom Tess(something) sells every month. You suckers fell for the story which I did too but luckily exited on every kite. The story sucks suckers in.
0 replies
Number_4 Nov 13, 5:46 PM
$HYPR Buyer at $.35, will cover my short from April on your tax loss selling. I warned you folks that Maria is an incompetent that parrots the same drivel at every CC. Just go ahead and sell now.
0 replies